2-(Chloromethyl)-5-methyl-1,3,4-oxadiazole → 5-tert-Butyl-3-(5-methyl-[1,3,4]oxadiazol-2-ylmethyl)-7-(2-oxa-6-aza-spiro[3.3]hept-6-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine

HRID 400947Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 400947
C(C1N=C(N2CCC(F)(F)C2)C2N=NN(CC)C=2N=1)(C)(C)C.[C:23]([C:27]1[N:28]=[C:29]([N:36]2[CH2:42][C:38]3([CH2:41][O:40][CH2:39]3)[CH2:37]2)[C:30]2[N:35]=[N:34][NH:33][C:31]=2[N:32]=1)([CH3:26])([CH3:25])[CH3:24].Cl[CH2:44][C:45]1[O:46][C:47]([CH3:50])=[N:48][N:49]=1>>[C:23]([C:27]1[N:28]=[C:29]([N:36]2[CH2:37][C:38]3([CH2:39][O:40][CH2:41]3)[CH2:42]2)[C:30]2[N:35]=[N:34][N:33]([CH2:44][C:45]3[O:46][C:47]([CH3:50])=[N:48][N:49]=3)[C:31]=2[N:32]=1)([CH3:26])([CH3:24])[CH3:25]

Komponenten

4

Edukt 3

HCID 38266202-(Chloromethyl)-5-methyl-1,3,4-oxadiazoleHCID 715582055-tert-Butyl-7-(3,3-difluoro-pyrrolidin-1-yl)-3-ethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidineHCID 178441781HCID 178441781, Verbindung

Produkt 1

HCID 866833585-tert-Butyl-3-(5-methyl-[1,3,4]oxadiazol-2-ylmethyl)-7-(2-oxa-6-aza-spiro[3.3]hept-6-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine

Versuchsvorschrift

In analogy to the procedure described for the synthesis of 5-tert-butyl-7-(3,3-difluoropyrrolidin-1-yl)-3-ethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (example 61), the title compound was prepared from 5-tert-Butyl-7-(2-oxa-6-aza-spiro[3.3]hept-6-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine and 2-(chloromethyl)-5-methyl-1,3,4-oxadiazole and isolated as white solid. MS (m/e): 371.2 (MH+).

Aufarbeitung

  1. customisolated as white solid

Quellen und Nachweise

ORD-Eintrag
ord-daa598ceb17e471d9b161dd8e26bb65b
Quelldatensatz
uspto-grants-2014_06
Patentnummer
US08741906B2

Notizen zur Reaktion

Wird geladen…